ArticleCancer chemotherapy and pharmacology2026
Crossing the toxicity threshold: a repeated landmark analysis of early toxicities and treatment modification during first-line CDK4/6 inhibitor therapy.
Tuğba Önder et al.PubMed ↗Publisher ↗
No numbers read from the abstract.